| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eab56e4fe8837840887f41af83e328ee |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-079 |
| filingDate |
2007-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42d2f3d4139959053d53c52c69104a82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1e854528f2570704aea81836c3115c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40fce0e876beda680be423e77860b0b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3cb6d1a9ff017411e15d97525d41501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2de70ac6c0729550aa7d98c37fbe6ce2 |
| publicationDate |
2009-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-102007044487-A1 |
| titleOfInvention |
Use of the Reverse Cell Differentiation Program (OCDP) to treat degenerated pathological organs |
| abstract |
ThenThe present invention relates to a method for treating degenerativenand / or organs in pathological condition by usenphenotypically stable, differentiating or differentiated,nbut not necessarily developmentallynterminal fixed cells from one according to the principles of the reversenCell Differentiation Program (OCDP) selected donor organnand use of such cells for treatment or manufacturena drug to treat it. Furthermore it concernsnthe present invention includes pharmaceutical agents comprising suitablenphenotypically stable cells, as well as donor cellsna first, with respect to the organ type of the second organndifferent organ used in the normal physiological statenwith respect to a predetermined set of expressed genesnand / or phenotypic properties reverse propertiesnto the second cells in the normal physiological state. |
| priorityDate |
2007-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |